Table 3.
Previous therapy history of conventional DMARDs.
| Patient | Gender | Age | Ocular inflammation | MTX | CTX | CsA | MMF | LEF | AZA |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Female | 59 | Keratitis | + | NA | NA | NA | NA | NA |
| 2 | Female | 45 | Anterior and intermediate uveitis | + | NA | NA | + | + | + |
| 3 | Female | 40 | Scleritis | + | + | NA | + | NA | + |
| 4 | Female | 22 | Anterior uveitis | + | NA | + | + | NA | NA |
| 5 | Female | 45 | Scleritis | NA | NA | NA | NA | NA | NA |
| 6 | Female | 43 | Panuveitis | NA | NA | NA | NA | + | NA |
| 7 | Female | 18 | Panuveitis | + | NA | NA | NA | NA | NA |
| 8 | Female | 37 | Anterior uveitis | + | NA | NA | NA | NA | + |
| 9 | Male | 21 | Panuveitis | + | NA | + | NA | NA | NA |
| 10 | Male | 65 | Scleritis | NA | NA | NA | + | NA | NA |
| 11 | Male | 43 | Conjunctivitis | + | + | NA | + | NA | NA |
Notes: MTX: methotrexate; CTX: cyclophosphamide; CsA: cyclosporine A; MMF: mycophenolate mofetil; LEF: leflunomide; AZA: azathioprine; NA: not available.